Key Events This Week
15 Sep: Lower circuit hit at Rs.121.52 amid heavy selling pressure
16 Sep: Second consecutive lower circuit at Rs.116.50; technical momentum shifts
17 Sep: Upper circuit hit at Rs.122.75 driven by strong buying interest
18 Sep: Upper circuit hit again at Rs.128.88, nearing 52-week high

Valiant Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-09-18 10:00:41At Rs 128.88, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 5% on 18 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Valiant Laboratories Ltd Locks at Upper Circuit With 4.78% Gain — Buyers Queue, Sellers Absent
2026-09-17 10:00:55At Rs 122.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Valiant Laboratories Ltd locked at its upper circuit of 4.78% on 17 Sep 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight
2026-09-16 10:01:00At Rs 116.5, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 16 Sep 2026, with unfilled sell orders and a frozen price, reflecting a day where supply overwhelmed demand to the point where the circuit breaker intervened.
Read full news article
Valiant Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-09-16 08:09:53Valiant Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish trend, amid a complex interplay of technical indicators. Despite a recent 5.00% decline in the stock price to ₹121.11, the company’s technical profile reveals a nuanced picture with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, suggesting cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector.
Read full news article
Valiant Laboratories Ltd Locks at Lower Circuit With 5.0% Loss — Sellers Queue, No Buyers in Sight
2026-09-15 12:00:11At Rs 121.52, sellers were still queuing — but there were no buyers willing to take the other side. Valiant Laboratories Ltd locked at its lower circuit of 5.0% on 15 Sep 2026, with unfilled sell orders and a frozen price.
Read full news articleValiant Laboratories Ltd Gains 18.84%: 8 Key Factors Driving the Surge
2026-09-12 10:03:11
Key Events This Week
07 Sep: New 52-week high at Rs.110.76
08 Sep: Upper circuit hit, closing at Rs.114.13
09 Sep: New 52-week high and upper circuit at Rs.119.83
10 Sep: New 52-week high and upper circuit at Rs.125.82
11 Sep: New 52-week high at Rs.130, followed by lower circuit hit at Rs.118.56

Broad-Based Technical Strength Lifts Valiant Laboratories Ltd to 52-Week High of Rs 130
2026-09-11 13:11:11After a sustained rally that has seen Valiant Laboratories Ltd gain 39.3% over the past eight trading days, the stock surged to a fresh 52-week high of Rs 130 on 11 Sep 2026, outpacing its sector and broader market indices despite a volatile session.
Read full news article
Valiant Laboratories Ltd is Rated Hold
2026-09-11 10:10:05Valiant Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 September 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Acquisition
17-Sep-2026 | Source : BSEPlease find enclosed
Board Meeting Outcome for Investment In AMPYR Renewable Energy Resources Twelve A Private Limited
17-Sep-2026 | Source : BSEPlease find enclosed
Announcement under Regulation 30 (LODR)-Newspaper Publication
04-Sep-2026 | Source : BSENewspaper Advertisement regarding Completion of Dispatch of Annual Report for FY 2025-26 and Notice of 5th Annual General Meeting to the Members of the Company
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Valiant Laboratories Ltd has announced 1:4 rights issue, ex-date: 18 Jul 25






